The City of El Paso will begin administering the new Bivalent COVID-19 booster vaccine to individuals 12 years of age and older beginning, Tuesday, September 20, 2022, at all City Community Clinics.
“This is another positive step forward in our battle against the COVID-19 virus. We are excited to be able to further protect our residents, slowing down the spread of the virus in their homes and our community,” said City-County Health Authority Dr. Hector Ocaranza. “Immunization is one of the most important things you can do to protect your health. Getting the vaccine and booster not only benefits you, but also your loved ones who can be infected with the virus.”
The FDA and CDC have approved a Bivalent COVID-19 Booster Vaccine, Pfizer bivalent vaccine is authorized for use in individuals 12 years of age and older and Moderna bivalent vaccine is authorized for anyone 18 years of age and older. This bivalent booster dose is administered as a single dose at least 2 months after either:
- Completion of primary vaccination with any authorized or approved monovalent COVID-19 vaccine, or
- Receipt of the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine.
The Bivalent COVID-19 booster will be administered at the following locations from 8 a.m. to 5 p.m. Tuesday through Saturday:
- 9341 Alameda
- 7380 Remcon
- 9566 Railroad
- 220 S. Stanton (Corner of First and Stanton)
COVID-19 vaccines do not require an appointment but are recommended to avoid long wait times. Appointments can be booked at EPCovidVaccine.com or by calling (915) 212-6843.
Symptomatic residents who would like to be tested at our City Clinics, are required to schedule a COVID-19 testing appointment by visiting EPStrong.org or by calling (915) 212-6843.
Health officials highly recommend residents continue practicing safety precautions such as washing your hands frequently, watching your distance and wearing a face covering, regardless of whether you have or have not yet received the vaccine.
For our complete coverage, Click Here